Intrinsic Value of S&P & Nasdaq Contact Us

CareCloud, Inc. CCLD NASDAQ

NASDAQ Global Market • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
$6.51
+114.9%
Analyst Price Target
$3.25
+7.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

CareCloud, Inc. (CCLD) trades at a trailing P/E of 102.4, forward P/E of 16.0. Trailing earnings yield is 0.98%, forward earnings yield 6.27%. PEG 0.18 (Peter Lynch undervalued ≤1.0). Graham Number is $0.32.

Criteria proven by this page:

  • VALUE (43/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 16.0 (down from trailing 102.4) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.18 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 0.98% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 6.27% as earnings recover.
  • Analyst consensus target $3.25 (+7.3% upside) — modest upside expected.

Overall SharesGrow Score: 53/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
53/100
SG Score
View full scorecard →
~
VALUE
43/100
Price-to-Earnings & upside
Proven by this page
FUTURE
82/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
29/100
→ Income
GROWTH
15/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — CCLD

Valuation Multiples
P/E (TTM)102.4
Forward P/E16.0
PEG Ratio0.18
Forward PEG0.18
P/B Ratio18.58
P/S Ratio1.03
EV/EBITDA4.4
Per Share Data
EPS (TTM)$0.03
Forward EPS (Est.)$0.19
Book Value / Share$0.16
Revenue / Share$0.32
FCF / Share$0.08
Yields & Fair Value
Earnings Yield0.98%
Forward Earnings Yield6.27%
Dividend Yield0.00%
Graham Number$0.32
SharesGrow IV$6.51 (+114.9%)
Analyst Target$3.25 (+7.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -0.8 -0.01 1.03 0.30 9.75%
2017 -5.2 0.12 1.44 0.92 5.09%
2018 -20.8 0.32 1.15 0.88 9.21%
2019 -56.3 0.94 1.15 0.76 12.45%
2020 -13.0 -0.01 1.14 1.09 9.90%
2021 32.4 -0.57 0.94 0.66 15.71%
2022 7.8 -0.60 0.42 0.31 36.07%
2023 -0.5 0.00 0.57 0.20 60.04%
2024 7.5 -0.08 1.19 0.53 -
2025 102.2 -0.75 18.55 9.16 0.57%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.88 $24.49M $-8.8M -35.9%
2017 $-0.51 $31.81M $-5.57M -17.5%
2018 $-0.18 $50.55M $-2.14M -4.2%
2019 $-0.07 $64.44M $-871.8K -1.4%
2020 $-0.70 $105.12M $-8.81M -8.4%
2021 $0.20 $139.6M $2.84M 2%
2022 $0.36 $138.83M $5.43M 3.9%
2023 $-4.11 $117.06M $-48.67M -41.6%
2024 $-0.28 $110.84M $7.85M 7.1%
2025 $0.10 $120.5M $10.8M 9%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.19 $0.17 – $0.20 $131.73M $131.22M – $132.23M 2
2027 $0.28 $0.27 – $0.28 $142.17M $141.38M – $142.95M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message